Hwa Yeon Ko
Overview
Explore the profile of Hwa Yeon Ko including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
7
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kim S, Ko H, Oh J, Yoon D, Kim J, Choe Y, et al.
J Korean Med Sci
. 2025 Jan;
40(3):e10.
PMID: 39834222
Background: Rare cases of Kawasaki disease (KD) and multisystem inflammatory syndrome in children (MIS-C) have been reported following the coronavirus disease 2019 (COVID-19) vaccination; however, the association between COVID-19 vaccination...
2.
Yoon D, Jung K, Kim J, Ko H, Yoon B, Shin J
Emerg Infect Dis
. 2024 Oct;
30(11):2313-2322.
PMID: 39378869
We conducted a self-controlled case series study to investigate the association between COVID-19 vaccination and facial palsy (FP) in South Korea. We used a large immunization registry linked with the...
3.
Bea S, Ko H, Bae J, Cho Y, Chang Y, Ryu S, et al.
Gut
. 2024 Sep;
74(2):284-294.
PMID: 39242193
Objective: To examine the hepatic effectiveness of sodium-glucose cotransporter-2 inhibitors (SGLT-2i) through a head-to-head comparison with glucagon-like peptide-1 receptor agonists (GLP-1RA) or thiazolidinediones (TZD) in patients with metabolic dysfunction-associated steatotic...
4.
Kim K, Ko H, Bea S, Lee H, Shin J, Chu M
J Clin Neurol
. 2024 Sep;
20(5):529-536.
PMID: 39227336
Background And Purpose: Migraine is one of the most common chronic neurological diseases worldwide. Although diverse treatment regimens have been recommended, there is insufficient evidence for which treatment patterns to...
5.
Hong B, Bea S, Ko H, Kim W, Cho Y, Shin J
Ann Intern Med
. 2024 Aug;
177(10):1319-1329.
PMID: 39186787
Background: Both sodium-glucose cotransporter-2 (SGLT2) inhibitors and glucagon-like peptide-1 receptor agonists (GLP-1 RAs) may have neuroprotective effects in patients with type 2 diabetes (T2D). However, their comparative effectiveness in preventing...
6.
Kim J, Yoon D, Ko H, Jung K, Sunwoo J, Shin W, et al.
BMC Med
. 2024 Mar;
22(1):123.
PMID: 38486297
Background: Several neurological manifestations shortly after a receipt of coronavirus infectious disease 2019 (COVID-19) vaccine have been described in the recent case reports. Among those, we sought to evaluate the...
7.
Yoon D, Kim J, Jeong H, Ko H, Kim S, Shin J
Allergy
. 2023 Dec;
79(3):754-757.
PMID: 38084802
No abstract available.
8.
Ko H, Bea S, Jeong H, Park S, Cho Y, Kong S, et al.
JAMA Netw Open
. 2023 Sep;
6(9):e2335797.
PMID: 37751205
Importance: Postmenopausal individuals with type 2 diabetes are susceptible to fractures due to the interaction of elevated blood glucose levels and a deficiency of the hormone estrogen. Despite continued concerns...
9.
Noh Y, Ko H, Kim J, Yoon D, Choe Y, Choe S, et al.
Epidemiol Health
. 2023 Jun;
45:e2023054.
PMID: 37309115
Objectives: This study investigated the reporting rates of adverse events following immunization (AEFIs) to the spontaneous reporting system (SRS) and its predictors among individuals with AEFIs after coronavirus disease 2019...